Protease inhibitor and gastric cancer.
D000328:Adult; D000368:Aged; D000510:Alpha-Globulins / Q000097:blood; D000990:Antithrombin III / Q000378:metabolism; D002918:Chymotrypsin / Q000037:antagonists & inhibitors / Q000097:blood; D003174:Complement C1 Inactivator Proteins / Q000097:blood; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D010958:Plasminogen / Q000378:metabolism; D011480:Protease Inhibitors / Q000097:blood*; D013274:Stomach Neoplasms / Q000097:blood*; D014361:Trypsin Inhibitors / Q000097:blood; D000514:alpha 1-Antichymotrypsin; D000515:alpha 1-Antitrypsin / Q000378:metabolism; D000511:alpha-Macroglobulins / Q000378:metabolism
D000510:Alpha-Globulins; D003174:Complement C1 Inactivator Proteins; D005338:Fibrin Fibrinogen Degradation Products; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D000514:alpha 1-Antichymotrypsin; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; C011877:inter-alpha-inhibitor; D000990:Antithrombin III; D005340:Fibrinogen; D010958:Plasminogen; D002918:Chymotrypsin